Fujifilm Middle East and Africa, a division of the globally renowned Fujifilm Corporation, is making a notable presence at Arab Health 2025, taking place from January 27 to 30 at the Dubai World Trade Centre.
The company is presenting its latest advancements in medical imaging technologies aimed at enhancing early screening, detection, and diagnostics.
Fujifilm is dedicated to improving clinical workflows and advancing preventative healthcare solutions. By integrating innovative image processing, artificial intelligence (AI), and practical applications across various domains such as Ultrasound, Endoscopy, Radiology Imaging, Healthcare IT systems, and In-Vitro Diagnostics, the company is enabling healthcare providers to detect diseases at earlier stages and ultimately transform healthcare delivery.
Among the key innovations on display at this year’s exhibition are the Digital Mammography System – Amulet Sophinity, featuring AI technology to streamline screening workflows, CAD EYE AI-powered computer-aided diagnosis for endoscopy that aids in early cancer detection, and the μTASWako i30 system, designed for liver cancer screening through high-risk biomarkers.
Michio Kondo, Managing Director of Fujifilm Middle East and Africa, highlighted the company’s continued commitment to advancing healthcare in the region.
“Our participation at Arab Health 2025 underscores our ongoing promise to promote best-in-class healthcare practices in the MEA region,”
Kondo said. He also pointed to the Fujifilm Technology Centre in the UAE, launched in 2020, as a pivotal hub for healthcare excellence, offering seminars, workshops, and training sessions to further Fujifilm’s mission of knowledge sharing.
Fujifilm’s innovations are setting new standards in the medical field, and their presence at Arab Health reinforces their commitment to advancing healthcare solutions across the Middle East and Africa.
News Source: Emirates News Agency
